TableĀ 1

Mycoplasma genitalium and Chlamydia trachomatis infection among NCSP and STI clinic attendees

InfectionClinic 2 N=716Clinic 1 N=1456NCSP N=2441Total N=4613
N (%, 95% CI)N (%, 95% CI)N (%, 95% CI)N (%, 95% CI)
M genitalium and C trachomatis3 (0.4, 0 to 0.9)4 (0.3, 0 to 0.6)16 (0.7, 0.4 to 1.0)23 (0.5, 0.3 to 0.7)
Total M genitalium38 (5.3, 3.7 to 7.0)43 (3.0, 2.0 to 3.9)57 (2.3, 1.7 to 2.9)138 (3.0, 2.5 to 3.5)
M genitalium only35 (4.9, 3.3 to 6.5)41 (2.8, 2.0 to 3.7)39 (1.6, 1.1 to 2.1)115 (2.5, 2.0 to 2.9)
Total C trachomatis23 (3.2, 1.9 to 4.5)60 (4.1, 3.1 to 5.1)166 (6.8, 5.8 to 7.8)249 (5.4, 4.8 to 6.1)
C trachomatis only20 (2.8, 1.6 to 4.0)56 (3.8, 2.9 to 4.8)150 (6.1, 5.2 to 7.1)226 (4.9, 4.3 to 5.5)
  • NCSP, National Chlamydia Screening Programme; M genitalium, Mycoplasma genitalium; C trachomatis, Chlamydia trachomatis; STI, sexually transmitted infection.